Patents by Inventor Michaela Giltner

Michaela Giltner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROSPHERE FORMULATIONS COMPRISING NALTREXONE AND METHODS FOR MAKING AND USING THE SAME
    Publication number: 20240000772
    Abstract: Microsphere formulations comprising naltrexone are provided. Methods of making and using the microsphere formulations are also provided.
    Type: Application
    Filed: September 14, 2023
    Publication date: January 4, 2024
    Inventors: Bradley Minrovic, Emma Murphy, Kaitlin Zemanski, Tracy Richey, Michaela Giltner
  • MICROSPHERE FORMULATIONS COMPRISING BTK INHIBITORS AND METHODS FOR MAKING AND USING THE SAME
    Publication number: 20230404922
    Abstract: Extended-release microsphere formulations comprising a BTK inhibitor are provided. In one aspect, the microsphere formulations are characterized in that the BTK inhibitor is ibrutinib, and the ibrutinib is released in vivo in humans over a period of from about 7 to about 28 days. Methods for making and using the formulations are also provided.
    Type: Application
    Filed: September 1, 2023
    Publication date: December 21, 2023
    Inventors: Michaela Giltner, Rachel Galaska, Tracy Richey, Mark Smith
  • MICROSPHERE FORMULATIONS COMPRISING KETAMINE AND METHODS FOR MAKING AND USING THE SAME
    Publication number: 20230225993
    Abstract: Extended-release injectable microsphere formulations comprising ketamine are provided. Methods for making and using the microsphere formulations are also provided.
    Type: Application
    Filed: January 9, 2023
    Publication date: July 20, 2023
    Applicant: Oakwood Laboratories, LLC
    Inventors: Rachel Galaska, Tracy Richey, Michaela Giltner